Last $0.0005 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 01/15/15 All times are local (Market data is delayed by at least 15 minutes).

genelink inc (GNLKQ) Snapshot

Open
$0.0005
Previous Close
$0.0005
Day High
$0.0005
Day Low
$0.0005
52 Week High
04/1/14 - $0.0099
52 Week Low
12/9/14 - $0.0003
Market Cap
132.5K
Average Volume 10 Days
10.8K
EPS TTM
$-0.01
Shares Outstanding
265.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GENELINK INC (GNLKQ)

Related News

No related news articles were found.

genelink inc (GNLKQ) Related Businessweek News

No Related Businessweek News Found

genelink inc (GNLKQ) Details

GeneLink, Inc. operates as a genetics-based personal healthcare company. The company develops a portfolio of DNA-based assessments to measure pre-dispositions to diseases and aging processes. Its products include GeneLink Healthy Aging, a twelve gene-SNP panel containing a cross section of basic functional health areas, including oxidation, bone health, cardiovascular health, lipid metabolism; and CoQ10 efficiency assessment, an antioxidant for cardiovascular, neuronal, and skin health. The company also provides oxidative stress assessment, a DNA-based tool to help measure an individual's inherent genetic capacity to combat oxidation; and nutragenetics nutritional assessment, which is used to identify variations in propensity for oxidation, detoxification, cardiovascular, immune health, neurological, pulmonary, and bone health. In addition, it offers dermagenetics skin health assessment that helps identify variations in genes related to skin aging, wrinkling, and overall skin health; and Dermagenetics skin care system, a system of personalized skin care products manufacturing based on a genetic assessment that measures single nucleotide polymorphisms (SNP) in DNA. Further, the company provides nutragenetics customized nutritional supplement system, a system of personalized nutritional supplement manufacturing based on a genetic assessment that measures SNPs in DNA; and a self-administered DNA collection system. Additionally, it focuses on the research and development of DNA testing and products for various condition-specific products compromising dementia and Alzheimer’s assessment, macular degeneration assessment, neurological health panel, DNA integrity and repair panel, and DNA collection kit. GeneLink, Inc. was founded in 1994 and is based in Orlando, Florida. On April 18, 2014, GeneLink Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Central District of Florida.

genelink inc (GNLKQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genelink inc (GNLKQ) Key Developments

GeneLink Inc. will Change its Ticker to GNLK.Q from GNLK

Effective April 30, 2014, GeneLink Inc. will change its Pink Sheets LLC stock ticker symbol to GNLK.Q from GNLK.

GeneLink Inc. announced delayed annual 10-K filing

On 04/01/2014, GeneLink Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

GeneLink, Inc. Appoints Michael G. Smith as Chief Operating Officer and Interim Chief Financial Officer

On November 12, 2013, GeneLink Inc. appointed Michael G. Smith as Chief Operating Officer and Interim Chief Financial Officer of the Company effective November 12, 2013. Michael G. Smith, age 47, has been employed by GeneLink Inc. as Sr. Vice President of Operations since September 1, 2012. Prior to that, Mr. Smith spent more than 25 years working for large public companies, working with high growth companies, and building startups.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNLKQ:US $0.00 USD 0.00

GNLKQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GNLKQ.
View Industry Companies
 

Industry Analysis

GNLKQ

Industry Average

Valuation GNLKQ Industry Range
No financial data is available for GNLKQ.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENELINK INC, please visit www.genelinkbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.